Clinical significance and relationship between gastric bare area involved in gastric carcinoma and expression of CD34, VEGF and VEGF-C
Xin Cheng, Ming Han, Shi-Zhuang Zhang, Peng Dong, Lin-Tao Qu
Abstract
Xin Cheng, Ming Han, Shi-Zhuang Zhang, Peng Dong, Lin-Tao Qu
Abstract
AIM: To detect the expression of CD34, vascular endothelial growth factor (VEGF) and vascular endothelial growth factor C (VEGF-C) in gastric carcinoma, and to investigate the clinical significance and relationship between the gastric bare area (GBA) involved in gastric carcinoma and expression of CD34, VEGF and VEGF-C. METHODS: Seventy-two cases of gastric carcinoma were divided into GBA involved and non- involved groups. Expression of CD34, VEGF and VEGF-C was detected by immunohistochemistry. RESULTS: In gastric carcinoma, there was no significant difference in the expression of VEGF (27/32 vs 28/40), CD34 (61.67±21.33 vs 60.79±22.04) or VEGF-C (23/32 vs 26/40) in GBA involved and non-involved groups. In proximal gastric carcinoma, there was no significant difference in the expression of VEGF (23/30 vs 6/9), CD34 (62.48±20.12 vs 61.79±23.68) and VEGF-C (20/30 vs 6/9) in GBA involved and non-involved groups. CONCLUSION: There was no relationship between the GBA involved in gastric carcinoma and expression of CD34, VEGF and VEGF-C. The anatomical structure of the GBA may result in poor prognosis of gastric carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To detect the expression of CD34, vascular endothelial growth factor (VEGF) and vascular endothelial growth factor C (VEGF-C) in gastric carcinoma, and to investigate the clinical significance and relationship between the gastric bare area (GBA) involved in gastric carcinoma and expression of CD34, VEGF and VEGF-C. METHODS: Seventy-two cases of gastric carcinoma were divided into GBA involved and non- involved groups. Expression of CD34, VEGF and VEGF-C was detected by immunohistochemistry. RESULTS: In gastric carcinoma, there was no significant difference in the expression of VEGF (27/32 vs 28/40), CD34 (61.67±21.33 vs 60.79±22.04) or VEGF-C (23/32 vs 26/40) in GBA involved and non-involved groups. In proximal gastric carcinoma, there was no significant difference in the expression of VEGF (23/30 vs 6/9), CD34 (62.48±20.12 vs 61.79±23.68) and VEGF-C (20/30 vs 6/9) in GBA involved and non-involved groups. CONCLUSION: There was no relationship between the GBA involved in gastric carcinoma and expression of CD34, VEGF and VEGF-C. The anatomical structure of the GBA may result in poor prognosis of gastric carcinoma.
Key concepts: VEGF receptors, Gastric carcinoma, CD34, Internal medicine, Clinical significance, Cancer research, Oncology, Medicine